Mingliang Chu

430 total citations
20 papers, 371 citations indexed

About

Mingliang Chu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Mingliang Chu has authored 20 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Mingliang Chu's work include Prostate Cancer Treatment and Research (5 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Mingliang Chu is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Mingliang Chu collaborates with scholars based in China, United States and Netherlands. Mingliang Chu's co-authors include Wei‐Qiang Gao, Helen He Zhu, Yanjing Guo, Ping Li, Ru Yang, Yunying Liu, Uyen B. Chu, Timur Mavlyutov, Jia Wang and Lian‐Wang Guo and has published in prestigious journals such as Nature Communications, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Mingliang Chu

20 papers receiving 370 citations

Peers

Mingliang Chu
Katayoon Rezaei United States
Soraya Sin France
Edward J. Sanderlin United States
Tim Kong United States
Elina Pietilä Finland
Miyuki Nomura Japan
Said Rahim United States
Zied Boudhraa France
Violaine Tribollet France
Katayoon Rezaei United States
Mingliang Chu
Citations per year, relative to Mingliang Chu Mingliang Chu (= 1×) peers Katayoon Rezaei

Countries citing papers authored by Mingliang Chu

Since Specialization
Citations

This map shows the geographic impact of Mingliang Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingliang Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingliang Chu more than expected).

Fields of papers citing papers by Mingliang Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingliang Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingliang Chu. The network helps show where Mingliang Chu may publish in the future.

Co-authorship network of co-authors of Mingliang Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingliang Chu. A scholar is included among the top collaborators of Mingliang Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingliang Chu. Mingliang Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jin, et al.. (2024). Emodin regulated lactate metabolism by inhibiting MCT1 to delay non-small cell lung cancer progression. Human Cell. 38(1). 11–11. 2 indexed citations
2.
Chu, Mingliang, et al.. (2023). Shikonin Suppresses Cell Tumorigenesis in Gastric Cancer Associatedwith the Inhibition of c-Myc and Yap-1. Combinatorial Chemistry & High Throughput Screening. 27(13). 1919–1929. 3 indexed citations
3.
Ren, Min, et al.. (2020). Detection of Klebsiella pneumoniae cfDNA in pleural fluid and its clinical value. Annals of Palliative Medicine. 9(5). 3379–3384. 5 indexed citations
4.
Chu, Mingliang, et al.. (2020). Detection of ALK Gene Rearrangement in Cell‐free RNA from Lung Cancer Malignant Pleural Effusion. BioMed Research International. 2020(1). 6124106–6124106. 5 indexed citations
5.
Ma, Liang, et al.. (2020). High expression of the CKIP-1 gene might promote apoptosis through downregulation of the Ras/ERK signalling pathway in the intestinal type of gastric cancer. Journal of International Medical Research. 48(3). 1220708577–1220708577. 6 indexed citations
6.
7.
Ma, Liang, et al.. (2019). Casein kinase 2 interacting protein 1 positively regulates caudal-related homeobox 1 in intestinal-type gastric cancer. Chinese Medical Journal. 133(2). 154–164. 5 indexed citations
8.
Zhang, Yun, Mingliang Chu, Lixin Wang, et al.. (2018). PARP6 acts as an oncogene and positively regulates Survivin in gastric cancer.. PubMed. 11(5). 2364–2371. 7 indexed citations
9.
Guo, Yanjing, Kai Zhang, Chaping Cheng, et al.. (2017). Numb−/low Enriches a Castration-Resistant Prostate Cancer Cell Subpopulation Associated with Enhanced Notch and Hedgehog Signaling. Clinical Cancer Research. 23(21). 6744–6756. 37 indexed citations
10.
Wang, Lixin, et al.. (2017). CKIP-1 serves as a negative regulator and correlates with the degree of differentiation in gastric cancer.. PubMed. 10(10). 10674–10680. 6 indexed citations
11.
Dong, Baijun, Yizhou Quan, Qianqian Chen, et al.. (2016). Regulation of Prostate Development and Benign Prostatic Hyperplasia by Autocrine Cholinergic Signaling via Maintaining the Epithelial Progenitor Cells in Proliferating Status. Stem Cell Reports. 6(5). 668–678. 9 indexed citations
12.
Chu, Mingliang, et al.. (2015). Regulation and Methylation of Tumor Suppressor MiR-124 by Androgen Receptor in Prostate Cancer Cells. PLoS ONE. 10(4). e0116197–e0116197. 27 indexed citations
13.
Chu, Uyen B., Timur Mavlyutov, Mingliang Chu, et al.. (2015). The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes. EBioMedicine. 2(11). 1806–1813. 81 indexed citations
14.
Wang, Jia, Helen He Zhu, Mingliang Chu, et al.. (2014). Symmetrical and asymmetrical division analysis provides evidence for a hierarchy of prostate epithelial cell lineages. Nature Communications. 5(1). 4758–4758. 56 indexed citations
15.
Chu, Mingliang, et al.. (2014). Hypermethylation-mediated transcriptional repression of TMPRSS2 in androgen receptor-negative prostate cancer cells. Experimental Biology and Medicine. 239(7). 823–828. 10 indexed citations
16.
Li, Xuefeng, Yunying Liu, Wenqi Chen, et al.. (2014). TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer. Oncotarget. 5(19). 9498–9513. 34 indexed citations
17.
Li, Ping, et al.. (2014). Zeb1 promotes androgen independence of prostate cancer via induction of stem cell-like properties. Experimental Biology and Medicine. 239(7). 813–822. 17 indexed citations
18.
19.
Chu, Mingliang, Peizeng Yang, Shengping Hou, et al.. (2011). Behçet's disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms. Human Immunology. 72(6). 525–529. 13 indexed citations
20.
Chu, Mingliang, Peizeng Yang, Shengping Hou, et al.. (2011). Elevated Serum Osteopontin Levels and Genetic Polymorphisms of Osteopontin Are Associated with Vogt-Koyanagi-Harada Disease. Investigative Ophthalmology & Visual Science. 52(10). 7084–7084. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katayoon Rezaei Breakdown of academic impact, for papers by Soraya Sin Breakdown of academic impact, for papers by Edward J. Sanderlin Breakdown of academic impact, for papers by Tim Kong Breakdown of academic impact, for papers by Elina Pietilä Breakdown of academic impact, for papers by Miyuki Nomura Breakdown of academic impact, for papers by Said Rahim Breakdown of academic impact, for papers by Zied Boudhraa Breakdown of academic impact, for papers by Violaine Tribollet
Rankless by CCL
2026